SpringerLink
Log in

Mental Health and the Microbiome: A Review of Psychological Impacts of Gut Microflora

  • Review
  • Published:
Current Pharmacology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Starting from scratch to understand what a microbiome is and its significance in our daily lives has become a crucial subject of study. This review aims to delve into the impact of diet on the gut microbiota and how alterations in the gut microflora can contribute to dysbiosis, anxiety, depression, and other neurological disorders.

Recent Findings

Over the past one decade, extensive research has been conducted to explore the role of the gut microbiome in mental health and its potential involvement in causing mental illnesses. Some studies have made hypotheses about how gut microbes can influence both psychological and neurological aspects. One primary area of investigation has been the impact of diet on sha** the composition of the gut microbiota and whether it can affect brain function or even play a role in the prevention or management of mental disorders such as depression, anxiety, schizophrenia, and Alzheimer's disease. These conditions and neurological diseases have garnered significant attention from the scientific community due to their growing burden on the field of medical science.

Summary

While many studies on the gut-brain axis (GBA) have traditionally focused on aspects like satiety and digestive processes, it is important to recognize that the gut microbiota constitutes a complex and dynamic ecosystem that plays a vital role in the overall functioning of the human body. Consequently, it exerts a profound influence on an individual's health and their susceptibility to various illnesses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. •• Ortega MA, Alvarez-Mon MA, García-Montero C, Fraile-Martinez O, Guijarro LG, Lahera G, et al. Gut microbiota metabolites in major depressive disorder—deep insights into their pathophysiological Roleand potential translational applications. Metabolites. 2022;12(1):50. https://doi.org/10.3390/metabo12010050. This article showed significant differences between gut eubiosis and dysbiosis in mental disorders like MDD with their different metabolite composition and concentrations were discussed in this study.

  2. •• Park W. Gut microbiomes and their metabolites shape human and animal health. J Microbiol. 2018;56(3):151–3. https://doi.org/10.1007/s12275-018-0577-8. This article discussed new discoveries of disease-associated microbiomes and suggest possible microbiome-based therapeutic approaches to human disease.

  3. Prakash S, Rodes L, Coussa-Charley M, Tomaro-Duchesneau C. Gut microbiota: next frontier in understanding human health and development of biotherapeutics. Biologics. 2011;5:71–86. https://doi.org/10.2147/BTT.S19099.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Clapp M, Aurora N, Herrera L, Bhatia M, Wilen E, Wakefield S. Gut microbiota’s effect on mental health: the gut-brain axis. Clin Pract. 2017;7(4):987. https://doi.org/10.4081/cp.2017.987.

    Article  PubMed  PubMed Central  Google Scholar 

  5. • Chakrabarti A, Geurts L, Hoyles L, Iozzo P, Kraneveld AD, La Fata G et al. The microbiota–gut–brain axis: pathways to better brain health. Perspectives on what we know, what we need to investigate and how to put knowledge into practice. Cell Mol Life Sci. 2022;79(2). https://doi.org/10.1007/s00018-021-04060-w. This paper discussed how the microbiota could become the target of nutritional and therapeutic strategies for improved brain health and well-being.

  6. Appleton J. The gut-brain axis: influence of microbiota on mood and mental health. Integr Med (Encinitas). 2018;17(4):28–32.

    PubMed  Google Scholar 

  7. • Verma H, Phian S, Lakra P, Kaur J, Subudhi S, Lal R et al. Human gut microbiota and mental health: advancements and challenges in microbe-based therapeutic interventions. Indian J Microbiol. 2020;60(4):405–19. https://doi.org/10.1007/s12088-020-00898-z. This review discussed the alterations in the gut microbes and its consequences in various neurological, psychological and neurodegenerative disorders.

  8. Carding S, Verbeke K, Vipond DT, Corfe BM, Owen LJ. Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis. 2015;26(26):26191. https://doi.org/10.3402/mehd.v26.26191.

    Article  PubMed  Google Scholar 

  9. Laguipo ABBB. Dysbiosis diagnosis; 2018. News-Medical.net [cited Sep 25, 2022]. Available from: https://www.news-medical.net/health/Dysbiosis-Diagnosis.aspx.

  10. •• Dicks LMT, Hurn D, Hermanus D. Gut bacteria and neuropsychiatric disorders. Microorganisms. 2021;9(12):2583. https://doi.org/10.3390/microorganisms9122583. This article is focused on the influence of gut bacteria and their metabolites on neuropsychiatric disorders.

  11. • Lee Y, Kim YK. Understanding the connection between the gut-brain axis and stress/anxiety disorders. Curr Psychiatry Rep. 2021;23(5):22. https://doi.org/10.1007/s11920-021-01235-x. This study suggested that onset of anxiety disorders may be correlated with activation of a microbiota-gut-brain mechanism involving the immune system, neurotransmitters, and the hormonal system.

  12. Pulikkan J, Mazumder A, Grace T. Role of the gut microbiome in autism spectrum disorders. Adv Exp Med Biol. 2019;1118:253–69. https://doi.org/10.1007/978-3-030-05542-4_13.

    Article  CAS  PubMed  Google Scholar 

  13. Anderson IM, Haddad PM, Scott J. Bipolar disorder. BMJ. 2012;345:e8508. https://doi.org/10.1136/bmj.e8508.

    Article  PubMed  Google Scholar 

  14. • Marazziti D, Buccianelli B, Palermo S, Parra E, Arone A, Beatino MF et al. The microbiota/microbiome and the gut-brain axis: how much do they matter in psychiatry? Life (Basel, Switzerland). 2021;11(8):760. https://doi.org/10.3390/life11080760. This paper reviewed and commented on the current literature on the role of the intestinal microbiota and the gut-brain axis in some common neuropsychiatric conditions.

  15. Sarkar A, Lehto SM, Harty S, Dinan TG, Cryan JF, Burnet PWJ. Psychobiotics and the manipulation of bacteria-gut-brain signals. Trends Neurosci. 2016;39(11):763–81. https://doi.org/10.1016/j.tins.2016.09.002.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Nemeroff CB. Psychoneuroimmuneendocrinology: the biological basis of mind-body physiology and pathophysiology. Depress Anxiety. 2013;30(4):285–7. https://doi.org/10.1002/da.22110.

    Article  PubMed  Google Scholar 

  17. • Flint J, Kendler KS. The genetics of major depression. Neuron. 2014;81(3):484–503. https://doi.org/10.1016/j.neuron.2014.01.027. This article reviewed the evidence of the genetic contribution to disease susceptibility and the current state of molecular approaches.

  18. Santomauro DF, Mantilla Herrera AM, Shadid J, Zheng P, Ashbaugh C, Pigott DM, et al. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398(10312):1700–12. https://doi.org/10.1016/S0140-6736(21)02143-7.

    Article  Google Scholar 

  19. Spichak S, Bastiaanssen TFS, Berding K, Vlckova K, Clarke G, Dinan TG, et al. Mining microbes for mental health: determining the role of microbial metabolic pathways in human brain health and disease. Neurosci Biobehav Rev. 2021;125:698–761. https://doi.org/10.1016/j.neubiorev.2021.02.044.

    Article  CAS  PubMed  Google Scholar 

  20. Spanogiannopoulos P, Bess EN, Carmody RN, Turnbaugh PJ. The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nat Rev Microbiol. 2016;14(5):273–87. https://doi.org/10.1038/nrmicro.2016.17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Morris G, Berk M, Carvalho A, Caso JR, Sanz Y, Walder K, et al. The role of the microbial metabolites including tryptophan catabolites and short chain fatty acids in the pathophysiology of immune-inflammatory and neuroimmune disease. Mol Neurobiol. 2017;54(6):4432–51. https://doi.org/10.1007/s12035-016-0004-2.

    Article  CAS  PubMed  Google Scholar 

  22. Sun M, Wu W, Liu Z, Cong Y. Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases. J Gastroenterol. 2017;52(1):1–8. https://doi.org/10.1007/s00535-016-1242-9.

    Article  CAS  PubMed  Google Scholar 

  23. •• McCarville JL, Chen GY, Cuevas VD, Troha K, Ayres JS. Microbiota metabolites in health and disease.Annu Rev Immunol. 2020; 26(38):147–70. https://doi.org/10.1146/annurev-immunol-071219-125715. This article discussed the recent advances in our mechanistic understanding of how microbiota-derived metabolites orchestrate and support physiological responses in the host, including immunity, inflammation, defense against infections, and metabolism.

  24. Roager HM, Licht TR. Microbial tryptophan catabolites in health and disease. Nat Commun. 2018;9(1):3294. https://doi.org/10.1038/s41467-018-05470-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Fülling C, Dinan TG, Cryan JF. Gut microbe to brain signaling: what happens in vagus neuron. Neuron. 2019;101(6):998–1002. https://doi.org/10.1016/j.neuron.2019.02.008.

    Article  CAS  PubMed  Google Scholar 

  26. • Kaur H, Singh Y, Singh S, Singh RB. Gut microbiome-mediated epigenetic regulation of brain disorder and application of machine learning for multi-omics data analysis. Genome. 2021;64(4):355–71. https://doi.org/10.1139/gen-2020-0136. This review examines our current understanding of epigenetic regulation of the GBA and proposes a framework to integrate multi-omics data for prediction, prevention, and development of precision health approaches to treat brain disorders.

  27. Zalar B, Haslberger A, Peterlin B. The role of microbiota in depression-a brief review. Psychiatr Danub. 2018;30(2):136–41. https://doi.org/10.24869/psyd.2018.136.

    Article  CAS  PubMed  Google Scholar 

  28. Szczesniak O, Hestad KA, Hanssen JF, Rudi K. Isovaleric acid in stool correlates with human depression. Nutr Neurosci. 2016;19(7):279–83. https://doi.org/10.1179/1476830515Y.0000000007.

    Article  CAS  PubMed  Google Scholar 

  29. Ríos-Covián D, Ruas-Madiedo P, Margolles A, Gueimonde M. De los Reyes-Gavilán CG, Salazar N. Intestinal short chain fatty acids and their link with diet and human health. Front Microbiol. 2016;7:185. https://doi.org/10.3389/fmicb.2016.00185.

    Article  PubMed  PubMed Central  Google Scholar 

  30. • Magistretti PJ, Allaman I. Lactate in the brain: from metabolic end-product to signalling molecule. Nat Rev Neurosci. 2018;19(4):235–49. https://doi.org/10.1038/nrn.2018.19. This paper described the role of lactate in ensuring adequate energy supply, modulating neuronal excitability levels and regulation of adaptive functions in order to set the 'homeostatic tone' of the nervous system.

  31. Machado-Vieira R, Zanetti MV, Otaduy MC, De Sousa RT, Soeiro-De-Souza MG, Costa AC, Carvalho AF, Leite CC, Busatto GF, Zarate CA, et al. Increased Brain Lactate during Depressive Episodes and Reversal Effects by Lithium Monotherapy in Drug-Naive Bipolar Disorder: A 3T 1H-MRS Study. J Clin Psychopharmacol. 2017;37:40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. • Karnib N, El-Ghandour R, El Hayek L, Nasrallah P, Khalifeh M, Barmo N, et al. Lactate is an antidepressant that mediates resilience to stress by modulating the hippocampal levels and activity of histone deacetylases. Neuropsychopharmacology. 2019;44(6):1152–62. https://doi.org/10.1038/s41386-019-0313-z. This paper examined whether lactate, a metabolite produced during exercise and known to reproduce specific brain exercise-related changes, promotes resilience to stress and acts as an antidepressant.

  33. Scaglia F. The role of mitochondrial dysfunction in psychiatric disease. Dev Disabil Res Rev. 2010;16(2):136–43. https://doi.org/10.1002/ddrr.115.

    Article  PubMed  Google Scholar 

  34. • Modoux M, Rolhion N, Mani S, Sokol H. Tryptophan metabolism as a pharmacological target. Trends Pharmacol Sci. 2021;42(1):60–73. https://doi.org/10.1016/j.tips.2020.11.006. This review described L-tryptophan metabolism and discussed the most recent pharmacological developments targeting it.

  35. Jenkins TA, Nguyen JC, Polglaze KE. Bertrand PP. Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axis. Nutrients. 2016;8(1):56. https://doi.org/10.3390/nu8010056.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Miura H, Ozaki N, Sawada M, Isobe K, Ohta T, Nagatsu TA. A Link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression. Stress. 2008;11(3):198–209. https://doi.org/10.1080/10253890701754068.

    Article  CAS  PubMed  Google Scholar 

  37. Chiang JYL. Bile acid metabolism and signaling. Compr Physiol. 2013;3(3):1191–212. https://doi.org/10.1002/cphy.c120023.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Flores-Ramos M, Burrola-Suárez MA, Guiza-Zayas R, Enciso-Araujo JM, Islas-Preciado D, Estrada Camarena EE. Evaluation of hormonal and metabolic factors related to depression in reproductive age women. Salud Ment. 2020;43(1):35–41. https://doi.org/10.17711/SM.0185-3325.2020.006.

    Article  Google Scholar 

  39. Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004;101(44):15718–23. https://doi.org/10.1073/pnas.0407076101.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. • Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005;102(31):11070–5. https://doi.org/10.1073/pnas.0504978102. This paper analyzed bacterial 16S rRNA gene sequences from the distal intestinal (cecal) microbiota of genetically obese ob/ob mice, lean ob/+ and wild-type siblings, and their ob/+ mothers, all fed the same polysaccharide-rich diet.

  41. •• Berding K, Vlckova K, Marx W, Schellekens H, Stanton C, Clarke G et al. Diet and the microbiota-gut-brain axis: sowing the seeds of good mental health. Adv Nutr. 2021;12(4):1239–85. https://doi.org/10.1093/advances/nmaa181. This paper summarized the current state of the literature triangulating diet, microbiota, and host behavior/brain processes and discuss potential underlying mechanisms.

  42. •• Turnbaugh P, Ley R, Mahowald M, Magrini V, Mardis E, Gordon J. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature, 2006 444(7122):1027–31. https://doi.org/10.1038/nature05414. This study demonstrated through metagenomic and biochemical analyses that these changes affect the metabolic potential of the mouse gut microbiota.

  43. Van de Wouw M, Schellekens H, Dinan T, Cryan J. Microbiota-Gut-Brain Axis: Modulator of Host Metabolism and Appetite. J Nutr. 2017;147(5):727–45. https://doi.org/10.3945/jn.116.240481.

    Article  CAS  PubMed  Google Scholar 

  44. • Hill-Burns E, Debelius J, Morton J, Wissemann W, Lewis M, Wallen Z, et al. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome. Mov Disord. 2017 32(5):739–49. https://doi.org/10.1002/mds.26942. This study determined if Parkinson's disease is associated with dysbiosis of gut microbiome, disentangle effects of confounders, and candidate taxa identification and functional pathways.

  45. Hopfner F, Künstner A, Müller S, Künzel S, Zeuner K, Margraf N, et al. Gut microbiota in Parkinson disease in a northern German cohort. Brain Res. 2017;15(1667):41–5. https://doi.org/10.1016/j.brainres.2017.04.019.

    Article  CAS  Google Scholar 

  46. •• Li Y, Shao L, Mou Y, Zhang Y, ** Y. Sleep, circadian rhythm and gut microbiota: alterations in Alzheimer's disease and their potential links in the pathogenesis. Gut Microbes. 2021.13(1):1957407. https://doi.org/10.1080/19490976.2021.1957407. This paper evaluated clinical and animal studies describing gut microbiota alterations in distinct conditions, including Alzheimer's disease, sleep and circadian disruption.

  47. Minter M, Hinterleitner R, Meisel M, Zhang C, Leone V, Zhang X, et al. Antibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APPSWE/PS1ΔE9 murine model of Alzheimer’s disease. Sci Rep. 2017;7(1):10411. https://doi.org/10.1038/s41598-017-11047-w.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Cuartero M, García-Culebras A, Nieto-Vaquero C, Fraga E, Torres-López C, Pradillo J, et al. The role of gut microbiota in cerebrovascular disease and related dementia. Br J Pharmacol. 2024;181(6):816–39. https://doi.org/10.1111/bph.16167.

    Article  CAS  PubMed  Google Scholar 

  49. • Sanchez-Rodriguez E, Egea-Zorrilla A, Plaza-Díaz J, Aragón-Vela J, Muñoz-Quezada S, Tercedor-Sánchez L, et al. The gut microbiota and its implication in the development of atherosclerosis and related cardiovascular diseases. Nutrients. 2020 12(3):605. https://doi.org/10.3390/nu12030605. This study discussed how external factors such as dietary and physical activity habits influence host-microbiota and its implication in atherogenesis, and pathogenesis of cardiovascular diseases.

  50. Zhu F, Ju Y, Wang W, Wang Q, Guo R, Ma Q, et al. Metagenome-wide association of gut microbiome features for schizophrenia. Nat Commun. 2020;11(1):1612. https://doi.org/10.1038/s41467-020-15457-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. • Sani G, Manchia M, Simonetti A, Janiri D, Paribello P, Pinna F, et al. The role of gut microbiota in the high-risk construct of severe mental disorders: a mini review. Front Psychiatry. 2021 11:585769. https://doi.org/10.3389/fpsyt.2020.585769. This study offered a developmental perspective and provided mechanistic insights on how changes in the microbiota could influence the risk of Severe mental disorders.

  52. •• Wang Q, Chen B, Sheng D, Yang J, Fu S, Wang J, et al. Multiomics analysis reveals aberrant metabolism and immunity linked gut microbiota with insomnia. Microbiol Spectr. 2022 10(5):e0099822. https://doi.org/10.1128/spectrum.00998-22. This study concluded that systemic inflammation and metabolites might be a pathway linking the gut microbiome with insomnia. The findings provided new insights and a better understanding of gut microbiota's role in insomnia.

Download references

Funding

Authors received no funding for this study.

Author information

Authors and Affiliations

  1. Department of Microbiology, Graphic Era (Deemed to be University), Dehradun, Uttarakhand, India

    Ananya Gupt, Sonal Naudiyal, Anju Rani & Sunil Kumar

Authors
  1. Ananya Gupt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sonal Naudiyal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anju Rani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sunil Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

AG, SN, AR and SK were involved in writing, image preparation and table preparation; AR & SK were involved in manuscript refinement and important intellectual content discussion.

Corresponding authors

Correspondence to Anju Rani or Sunil Kumar.

Ethics declarations

Competing interests

The authors declare no competing interests.

Conflict of Interest

The authors declare no conflict of interests.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gupt, A., Naudiyal, S., Rani, A. et al. Mental Health and the Microbiome: A Review of Psychological Impacts of Gut Microflora. Curr. Pharmacol. Rep. (2024). https://doi.org/10.1007/s40495-024-00357-z

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s40495-024-00357-z

Keywords

Search

Navigation